Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 Jan 25 | EXEL Exelixis | Common Stock | Payment of exercise | Dispose F | No | No | 37.27 | 35,949 | 1.34 mm | 801,198 |
16 Jan 25 | EXEL Exelixis | Common Stock | Grant | Acquire A | No | No | 0 | 132,973 | 0.00 | 837,147 |
2 Jan 25 | QNCX Quince Therapeutics | Director Stock Option Common Stock | Grant | Acquire A | No | No | 1.88 | 35,274 | 66.32 k | 35,274 |
15 Nov 24 | EXEL Exelixis | Common Stock | Payment of exercise | Dispose F | No | No | 35.05 | 17,506 | 613.59 k | 704,174 |
9 Aug 24 | EXEL Exelixis | Common Stock | Sell | Dispose S | No | No | 27.19 | 125,000 | 3.40 mm | 721,680 |
9 Aug 24 | EXEL Exelixis | Common Stock | Option exercise | Acquire M | No | No | 24.41 | 125,000 | 3.05 mm | 846,680 |
9 Aug 24 | EXEL Exelixis | Option Common Stock | Option exercise | Dispose M | No | No | 24.41 | 125,000 | 3.05 mm | 0 |
5 Jun 24 | QNCX Quince Therapeutics | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 0.82 | 27,000 | 22.14 k | 27,000 |